Champlain Investment Partners LLC Has $26.27 Million Stock Position in TriMas Co. (NASDAQ:TRS)

Champlain Investment Partners LLC decreased its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,068,253 shares of the industrial products company's stock after selling 62,076 shares during the period. Champlain Investment Partners LLC owned 2.63% of TriMas worth $26,268,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of TriMas by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 3,895,946 shares of the industrial products company's stock worth $95,801,000 after purchasing an additional 82,068 shares in the last quarter. Bellecapital International Ltd. acquired a new position in shares of TriMas in the 4th quarter worth approximately $29,160,000. Medina Value Partners LLC raised its position in shares of TriMas by 2.9% during the 4th quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company's stock valued at $25,448,000 after acquiring an additional 28,851 shares in the last quarter. State Street Corp lifted its stake in TriMas by 4.1% during the third quarter. State Street Corp now owns 994,114 shares of the industrial products company's stock worth $25,380,000 after purchasing an additional 39,497 shares during the last quarter. Finally, Advisory Research Inc. boosted its holdings in TriMas by 41.2% in the fourth quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock worth $18,543,000 after purchasing an additional 220,000 shares during the period. 99.42% of the stock is currently owned by institutional investors and hedge funds.

TriMas Stock Performance

NASDAQ:TRS traded up $0.43 during mid-day trading on Wednesday, hitting $21.22. The stock had a trading volume of 84,770 shares, compared to its average volume of 303,894. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. The company has a 50 day simple moving average of $22.55 and a 200-day simple moving average of $24.48. The stock has a market capitalization of $863.99 million, a price-to-earnings ratio of 33.16 and a beta of 0.55. TriMas Co. has a 52 week low of $19.33 and a 52 week high of $28.51.

TriMas Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th will be given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.75%. TriMas's dividend payout ratio (DPR) is 27.12%.

Insider Transactions at TriMas

In other TriMas news, Director Jeffrey A. Fielkow purchased 2,500 shares of the business's stock in a transaction on Friday, February 28th. The stock was bought at an average cost of $20.78 per share, with a total value of $51,950.00. Following the acquisition, the director now owns 11,013 shares of the company's stock, valued at $228,850.14. The trade was a 29.37 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Shawn Sedaghat acquired 554,149 shares of TriMas stock in a transaction dated Monday, March 10th. The shares were bought at an average cost of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the purchase, the director now owns 900,974 shares in the company, valued at approximately $21,686,444.18. This represents a 159.78 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders purchased 806,246 shares of company stock valued at $19,338,213. Company insiders own 14.20% of the company's stock.

Analyst Upgrades and Downgrades

Separately, BWS Financial reaffirmed a "buy" rating and issued a $40.00 price target on shares of TriMas in a report on Friday, February 28th.

TriMas Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.